Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
05/2008
05/15/2008WO2008055880A1 Process for the sulfinylation of a pyrazole derivative
05/15/2008WO2008055879A1 Process for the sulfinylation of a pyrazole derivative
05/15/2008WO2008055877A1 Process for the sulfinylation of a pyrazole derivative
05/15/2008WO2008055710A1 Indole and indazole derivatives as anti-inflammatory agents
05/15/2008WO2008055709A1 Indazole and indole derivatives as anti -inflammatory agents
05/15/2008WO2008012227A3 Pyrazoles as glucokinase activators
05/15/2008US20080114175 Processes and Intermediates Preparing Cysteine Protease Inhibitors
05/15/2008US20080114158 Yellow anionic disazo dyes
05/15/2008US20080113968 Substituted piperazines and diazepanes
05/15/2008US20080113967 Enzyme modulators and treatments
05/15/2008CA2667565A1 Process for the sulfinylation of a pyrazole derivative
05/15/2008CA2667562A1 Process for the sulfinylation of a pyrazole derivative
05/15/2008CA2667559A1 Process for the sulfinylation of a pyrazole derivative
05/15/2008CA2644333A1 Reaction reagent for trifluoromethylation
05/14/2008EP1921069A1 Process for preparing 2-alkyl-3-heterocyclyl-prop-2-en-1-ols
05/14/2008EP1921068A1 Indazole and indole derivatives as anti-inflammatory agents
05/14/2008EP1921067A1 Indole and indazole derivatives as anti-inflammatory agents
05/14/2008EP1919913A2 P38 map kinase inhibitors and methods for using the same
05/14/2008EP1919887A2 Method for enantioselective hydrogenation of chromenes
05/14/2008EP1919877A1 P38 map kinase inhibitors and methods for using the same
05/14/2008EP1919876A1 Method for producing substituted pyrazoles
05/14/2008EP1919875A2 Pyrazole derivatives and their use as pka and pkb modulators
05/14/2008EP1756064B1 Pyrazole derivatives, compositions containing such compounds and methods of use
05/14/2008EP1575922B1 Biphenyl derivatives and their use as fungicides
05/14/2008EP1446375B1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents
05/14/2008CN101180275A Pyridine, and pyridazine derivatives
05/14/2008CN101180274A Metal complex, light-emitting device and display
05/14/2008CN101177427A Compound polycrystalline type alpha and solvate for hypnotism, preparation method and combination including the same
05/14/2008CN100387598C Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
05/13/2008US7371871 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents, sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents, drug abuse withdrawl
05/13/2008US7371868 Bactericides; 2-[(1R)-1-methyl-2-trityl-2,3-dihydro-1H-5-isoindolyl]-1,3,6,2-dioxazaborocane.
05/13/2008US7371767 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5
05/08/2008WO2008053991A1 Substituted pyrazolecarboxanilide derivative or salt thereof, agricultural or horticultural chemical, and method of using the same
05/08/2008WO2008053976A1 Metal complex, luminescent device and display apparatus
05/08/2008WO2008053764A1 Anti-prion active compound, anti-prion active agent, and method for inhibition of the production of abnormal prion protein
05/08/2008WO2008053652A1 Process for production of hydroxyadamantaneamine
05/08/2008WO2008053300A1 Pyrazoline compounds as mineralocorticoid receptor antagonists
05/08/2008WO2008052974A1 3-amino-pyrazole-4-carboxamide derivatives useful as inhibitors of protein kinases
05/08/2008WO2008052898A1 Indazole derivatives useful as l-cpt1 inhibitors
05/08/2008WO2008052808A1 Cyclic phenyl-substituted indazols, a process for their production and their use as anti-inflammatory agents
05/08/2008WO2008052441A1 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
05/08/2008WO2008034863A3 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
05/08/2008WO2008024302A8 Compounds for treating proliferative disorders
05/08/2008WO2007136607A3 Substituted esters as cannabinoid-1 receptor modulators
05/08/2008WO2007067814A3 Targeting gli proteins in human cancer by small molecules
05/08/2008US20080108829 Substituted pyrazoles, indazoles, 1,2,3-triazoles, or benzotriazoles; anticarcinogenic agents, antiinflammatory agents, antiarthritic agents, transplant rejection; controlled release formulations; aralkylation and amidation of the indazole compound
05/08/2008US20080108821 Method for preparing 3-halo-4,5-dihydro-1H-pyrazoles
05/08/2008US20080108686 N-(Ortho-Phenyl)-1-Methyl-3-Difluoromethylpyrazole-4-Carboxanilides And Their Use As Fungicides
05/08/2008US20080108668 compounds with biological activity against all sorts of plant diseases and insects at very low dosage, to control plant diseases like cucumber downy mildew, cucumber grey mold, cucumber powdery mildew, tomato early blight, tomato late blight, phytophthora blight of pepper, grape downy mildew and etc
05/08/2008US20080108626 (5-amino-1-phenyl-1H-pyrazole)-(3-Amino-N-isoxazol-3-yl-4-methyl)-benzamide; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease
05/08/2008CA2668491A1 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation
05/08/2008CA2667927A1 3-amino-pyrazole-4-carboxamide derivatives useful as inhibitors of protein kinases
05/08/2008CA2667685A1 Indazole derivatives useful as l-cpt1 inhibitors
05/07/2008EP1917963A1 Cyclic phenyl-substituted indazols, a process for their production and their use as anti-inflammatory agents
05/07/2008EP1917262A1 Piperidine and piperazine derivatives as p2x3 antagonists
05/07/2008EP1917249A1 3-oxo-indazole-squaric acid derivatives
05/07/2008EP1917248A1 1-acyldihydropyrazol derivatives
05/07/2008EP1917247A1 4,5-dihydr0-1h-pyrazole derivatives, their preparation and use as medicaments
05/07/2008EP1917240A1 Immunosuppressant compounds and compositions
05/07/2008EP1916896A2 Non-steroidal antiandrogens
05/07/2008EP1509216B1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol
05/07/2008CN101175729A 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof
05/07/2008CN101175728A Process for the preparation of a carboxamide derivative
05/07/2008CN101175727A Pyrazolocarboxamides as fungicides
05/07/2008CN101172983A Substituted phenylacetic acids
05/06/2008US7368572 Anticancer agents
05/06/2008US7368539 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
05/06/2008US7368479 Alpha-sulfonylamino-acetonitriles
05/06/2008US7368224 Photopolymerizable composition
05/06/2008CA2244979C Proton conductor in liquid form
05/02/2008WO2008051532A1 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
05/02/2008WO2008050167A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists
05/02/2008WO2008011611A3 Compounds and compositions as itpkb inhibitors
05/02/2008CA2667007A1 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydrocyclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
05/01/2008US20080103313 Dyes that are Soluble in Organic Solvents
05/01/2008US20080103182 N-[1-(4-Difluoromethoxy-benzyl)-1H-indazol-3-yl]-terephthalamic acid;liver carnitine palmitoyl transferase 1 (L-CPT1) nhibitor; antidiabetic and hypotensive agent; obesity, insulin resistance, hyperglycemia; reduce liver beta -oxidation, consequently inhibit gluconeogenesis
04/2008
04/30/2008EP1915431A2 Process for printing an image, composition and compound
04/30/2008EP1915430A2 Process for printing an image, composition and compound
04/30/2008EP1915352A1 Compounds for the treatment of alzheimer's disease
04/30/2008EP1915348A1 Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
04/30/2008EP1915347A1 New 1 , 2 -diaryl pyrazoles useful as analgetic and anti-inflammatory agents
04/30/2008CN101171235A Dipyrazoles as central nervous system agents
04/30/2008CN101168529A Fipronil, ethiprole and synthesizing method for derivative thereof
04/30/2008CN100384827C Ophthalmic compositions for treating ocular hypertension
04/30/2008CN100384420C Use of substituted pyrazoles in preparing medicine compositions for treating allergies
04/29/2008US7365211 Heterocyclic GABAA subtype selective receptor modulators
04/29/2008US7365085 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
04/29/2008US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate
04/29/2008CA2343204C Arylsulfonanilide ureas
04/24/2008WO2008047210A2 Compounds derived from 1 -ethyl-4,5-diamino-pyrazole and their use for oxidative dyeing of keratin fibres
04/24/2008WO2008046527A1 Acylaminopyrazoles for treating cardiovascular diseases
04/24/2008WO2008008286A3 Substituted pyrazoles as ghrelin receptor antagonists
04/24/2008US20080097108 Potassium channel blocker; neuroprotectants; glaucoma; 1-(7-Methoxy-1,2,3,4-tetrahydro-9H-carbazol-9-yl)-3,3-dimethylbutan-2-one; N,N-Dibutyl-2-(7-methoxy-1,2,3,4-tetrahydro-9H-carbazol-9-yl)acetamide
04/24/2008US20080096950 Compounds Useful In Therapy
04/24/2008US20080096949 Indazolyl-substituted pyrroline compounds as kinase inhibitors
04/24/2008US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
04/24/2008US20080096913 peroxisome proliferator-activated receptor agonists; congestive heart failure, atherosclerosis, arteriosclerosis, obesity, hyperlipidemia, hypoalphalipoproteinemia, Syndrome X, diabetes, insulin resistance; 3-[5-Methoxy-1-(3-methoxy-benzyl)-1H-indol-3-yl]-propionic acid
04/24/2008US20080096887 Benzene, Pyridine, and Pyridazine Derivatives
04/24/2008DE102006048924A1 Acylaminopyrazole Acylaminopyrazole
04/24/2008CA2666401A1 Acylaminopyrazoles for treating cardiovascular diseases
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 256